Rx-to-OTC switch strategies in the US are evolving as the FDA’s Additional Conditions for Nonprescription Use (ACNU) framework opens new pathways to market for products requiring specific patient protocols.
Join IQVIA Consumer Health and Idea Evolver on Tuesday, 24 March for a live expert discussion on how these regulatory developments are influencing decision-making, expanding innovation potential, and shaping the next phase of OTC growth in the United States.
During this free online webinar, we will explore:
Click the Register button to secure your place.
Shape the future of consumer health.
Compelling claims to capture the minds of consumers
Navigate regulatory pathways with confidence
.svg){kind=icon}
